Explicit solutions for a class of indirect pharmacodynamic response models

Area of Science:

• Pharmacokinetics and Pharmacodynamics
• Mathematical Modeling
• Computational Biology

Background:

• Indirect response models are crucial for describing drug effects over time.
• Existing models often rely on ordinary differential equations (ODEs).
• Emax functions are commonly used to model inhibitory or stimulatory drug effects.

Purpose of the Study:

• To derive and present explicit analytical solutions for four types of ODE-based indirect response models.
• To demonstrate the application of these solutions in a real-world pharmacokinetic/pharmacodynamic (PK/PD) scenario.
• To highlight the computational advantages of explicit solutions over numerical ODE implementations.

Main Methods:

• Derivation of explicit solutions using hypergeometric 2F1 functions.
• Analytical continuation of these functions.
• Application to modeling the pharmacodynamics of ibandronate, a bone turnover inhibitor.

Main Results:

• Explicit solutions were successfully derived for the specified indirect response models.
• The explicit solutions were validated through application to ibandronate kinetics.
• Model evaluation using explicit solutions was found to be up to ten times faster than ODE implementations.

Conclusions:

• Explicit solutions provide an efficient alternative to ODEs for indirect response models.
• This computational efficiency can significantly benefit large-scale simulations and parameter estimation in drug development.
• The methodology is applicable to various drugs exhibiting inhibitory or stimulatory Emax pharmacodynamic effects.